Executive Vice President and the Director of Chemical and Pharmaceutical Science
Dr. Josh Bloom, ACSH's Executive Vice President and the Director of Chemical and Pharmaceutical Science, earned his Ph.D. in organic chemistry at the University of Virginia, followed by postdoctoral training at the University of Pennsylvania. His career 20+ year career in drug discovery research began at Lederle Laboratories, which was acquired by Wyeth in 1994, which itself was acquired by Pfizer in 2009. During this time he participated in research in a number of therapeutic areas, including diabetes and obesity, antibiotics, HIV/AIDS, hepatitis C, and oncology. His group discovered the novel antibiotic Tygacil®, which was approved by the FDA for use against resistant bacterial infections in 2005. He is the author of 25 patents, and 35 academic papers, including a chapter on new therapies for hepatitis C in Burger’s Medicinal Chemistry, Drug Discovery and Development, 7th Edition (Wiley, 2010).
Dr. Bloom, who joined the American Council on Science and Health in 2010 as Director of Chemical and Pharmaceutical Sciences, has published more than 75 op-eds in numerous periodicals, including The Wall Street Journal, Forbes, New Scientist, The New York Post, National Review Online, The Boston Herald, The Baltimore Sun, and The Chicago Tribune, and also done numerous radio and television shows and podcasts on topics related to drugs and chemicals.
He is now recognized as an expert in government opioid policy and was the first journalist to write a nationally published opinion piece about the unintended consequences of a governmental crackdown on prescription pain medications (New York Post, 2013). Since that time he has published more than 20 op-eds in regional and national newspapers on different aspects of the crisis.
He was also the first writer (2016) to study, dissect and ultimately debunk the manipulated statistics used by the CDC to justify its recommendations for opioid prescribing, which have resulted in Draconian requirements for prescribing pain medications as well as government-mandated, involuntary tapering of patients receiving opioid treatment, both of which have caused great harm and needless suffering to chronic pain patients. His 2016 article, "Six Charts Designed to Confuse You," is considered to be the seminal work on CDC deception and has been adopted by patient advocacy groups. It has been sent to governors, senators and state legislatures.